Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rehman, Shafiq Ur | - |
dc.contributor.author | Ikram, Muhammad | - |
dc.contributor.author | Ullah, Najeeb | - |
dc.contributor.author | Alam, Sayed Ibrar | - |
dc.contributor.author | Park, Hyun Young | - |
dc.contributor.author | Badshah, Haroon | - |
dc.contributor.author | Choe, Kyonghwan | - |
dc.contributor.author | Kim, Myeong Ok | - |
dc.date.accessioned | 2022-12-26T14:47:06Z | - |
dc.date.available | 2022-12-26T14:47:06Z | - |
dc.date.created | 2022-12-13 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gnu/handle/sw.gnu/8978 | - |
dc.description.abstract | Oxidative stress and energy imbalance strongly correlate in neurodegenerative diseases. Repeated concussion is becoming a serious public health issue with uncontrollable adverse effects in the human population, which involve cognitive dysfunction and even permanent disability. Here, we demonstrate that traumatic brain injury (TBI) evokes oxidative stress, disrupts brain energy homeostasis, and boosts neuroinflammation, which further contributes to neuronal degeneration and cognitive dysfunction in the mouse brain. We also demonstrate that melatonin (an anti-oxidant agent) treatment exerts neuroprotective effects, while overcoming oxidative stress and energy depletion and reducing neuroinflammation and neurodegeneration. Male C57BL/6N mice were used as a model for repetitive mild traumatic brain injury (rmTBI) and were treated with melatonin. Protein expressions were examined via Western blot analysis, immunofluorescence, and ELISA; meanwhile, behavior analysis was performed through a Morris water maze test, and Y-maze and beam-walking tests. We found elevated oxidative stress, depressed phospho-5'AMP-activated protein kinase (p-AMPK) and phospho- CAMP-response element-binding (p-CREB) levels, and elevated p-NF-kappa B in rmTBI mouse brains, while melatonin treatment significantly regulated p-AMPK, p-CREB, and p-NF-kappa B in the rmTBI mouse brain. Furthermore, rmTBI mouse brains showed a deregulated mitochondrial system, abnormal amyloidogenic pathway activation, and cognitive functions which were significantly regulated by melatonin treatment in the mice. These findings provide evidence, for the first time, that rmTBI induces brain energy imbalance and reduces neuronal cell survival, and that melatonin treatment overcomes energy depletion and protects against brain damage via the regulation of p-AMPK/p-CREB signaling pathways in the mouse brain. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | AMYLOID PRECURSOR PROTEIN | - |
dc.subject | TRANSCRIPTIONAL REGULATION | - |
dc.subject | AMPK ACTIVATION | - |
dc.subject | KINASE | - |
dc.subject | APOPTOSIS | - |
dc.subject | PATHWAY | - |
dc.subject | BETA | - |
dc.subject | DEGENERATION | - |
dc.subject | MECHANISMS | - |
dc.subject | INHIBITION | - |
dc.title | Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Myeong Ok | - |
dc.identifier.doi | 10.3390/cells8070760 | - |
dc.identifier.scopusid | 2-s2.0-85074733188 | - |
dc.identifier.wosid | 000478902000025 | - |
dc.identifier.bibliographicCitation | CELLS, v.8, no.7 | - |
dc.relation.isPartOf | CELLS | - |
dc.citation.title | CELLS | - |
dc.citation.volume | 8 | - |
dc.citation.number | 7 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | TRANSCRIPTIONAL REGULATION | - |
dc.subject.keywordPlus | AMPK ACTIVATION | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | BETA | - |
dc.subject.keywordPlus | DEGENERATION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordAuthor | rmTBI melatonin | - |
dc.subject.keywordAuthor | AMPK | - |
dc.subject.keywordAuthor | CREB | - |
dc.subject.keywordAuthor | neurodegeneration | - |
dc.subject.keywordAuthor | amyloid beta | - |
dc.subject.keywordAuthor | synaptic dysfunction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.